More on AUTL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.56 |
|
|||
| Open | $1.57 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.64 | ||||
| Day Low | $1.52 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,019,628 | ||||
- Autolus Therapeutics Receives Prix Galien UK Award
- Form 8-K Autolus Therapeutics For: Jun 05
- Autolus Therapeutics to Participate in Upcoming Investor Conferences
- Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
- Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
- Byondis forms scientific advisory board with oncology experts
- Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
- Form SCHEDULE 13G/A Autolus Therapeutics Filed by: MAK Capital Fund LP
- Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
- Autolus Therapeutics plc (AUTL) PT Lowered to $5.40 at Goldman Sachs
Entities mentioned with AUTL
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- William Blair | View Related Stories »
- Wells Fargo | View Related Stories »
- JPMorgan | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
